1. Product Overview
1.1. Market Definition
1.2. Scope of the Market
1.2.1. Markets Covered
1.2.2. Years Considered for
Study
1.2.3. Key Market
Segmentations
2. Research Methodology
2.1. Objective of the Study
2.2. Baseline Methodology
2.3. Key Industry Partners
2.4. Major Association and Secondary Sources
2.5. Forecasting Methodology
2.6. Data Triangulation & Validation
2.7. Assumptions and Limitations
3. Executive Summary
3.1. Overview of the
Market
3.2. Overview of Key
Market Segmentations
3.3. Overview of Key
Market Players
3.4. Overview of Key Regions/Countries
3.5. Overview of Market
Drivers, Challenges, Trends
4. Voice of Customer
5. Clinical Trial
Analysis
5.1. Ongoing Clinical
Trials
5.2. Completed Clinical
Trials
5.3. Terminated Clinical
Trials
5.4. Breakdown of
Pipeline, By Development Phase
5.5. Breakdown of
Pipeline, By Status
5.6. Breakdown of
Pipeline, By Study Application
5.7. Breakdown of
Pipeline, By Region
5.8. Clinical Trials Heat
Map
6.
Global Exosome Therapeutics Market Outlook
6.1. Market Size &
Forecast
6.1.1. By Value
6.2. Market Share &
Forecast
6.2.1. By Exosome Type (Natural v/s Hybrid)
6.2.2. By Source (Mesenchymal Stem Cells, Blood, Body Fluids,
Others)
6.2.3. By Therapy (Immunotherapy, Chemotherapy, Gene Therapy)
6.2.4. By Application (Metabolic Disorders, Oncology, Cardiac
Disorders, Neurology, Others)
6.2.5. By End User (Hospitals & Clinics, Academic &
Research Institutions, Others)
6.2.6. By Company (2021)
6.2.7. By Region
6.3. Market Map
7.
North America Exosome Therapeutics Market Outlook
7.1. Market Size &
Forecast
7.1.1. By Value
7.2. Market Share &
Forecast
7.2.1. By Exosome Type
7.2.2. By Source
7.2.3. By Therapy
7.2.4. By Application
7.2.5. By End User
7.2.6. By Country
7.3. North America:
Country Analysis
7.3.1. United States
Exosome Therapeutics Market Outlook
7.3.1.1.
Market Size & Forecast
7.3.1.1.1.
By Value
7.3.1.2.
Market Share & Forecast
7.3.1.2.1.
By Exosome Type
7.3.1.2.2.
By Source
7.3.1.2.3.
By Therapy
7.3.1.2.4.
By Application
7.3.1.2.5.
By End User
7.3.2. Mexico Exosome
Therapeutics Market Outlook
7.3.2.1.
Market Size & Forecast
7.3.2.1.1.
By Value
7.3.2.2.
Market Share & Forecast
7.3.2.2.1.
By Exosome Type
7.3.2.2.2.
By Source
7.3.2.2.3.
By Therapy
7.3.2.2.4.
By Application
7.3.2.2.5.
By End User
7.3.3. Canada Exosome
Therapeutics Market Outlook
7.3.3.1.
Market Size & Forecast
7.3.3.1.1.
By Value
7.3.3.2.
Market Share & Forecast
7.3.3.2.1.
By Exosome Type
7.3.3.2.2.
By Source
7.3.3.2.3.
By Therapy
7.3.3.2.4.
By Application
7.3.3.2.5.
By End User
8.
Europe Exosome Therapeutics Market Outlook
8.1. Market Size &
Forecast
8.1.1. By Value
8.2. Market Share &
Forecast
8.2.1. By Exosome Type
8.2.2. By Source
8.2.3. By Therapy
8.2.4. By Application
8.2.5. By End User
8.2.6. By Country
8.3. Europe: Country
Analysis
8.3.1. France Exosome Therapeutics
Market Outlook
8.3.1.1.
Market Size & Forecast
8.3.1.1.1.
By Value
8.3.1.2.
Market Share & Forecast
8.3.1.2.1.
By Exosome Type
8.3.1.2.2.
By Source
8.3.1.2.3.
By Therapy
8.3.1.2.4.
By Application
8.3.1.2.5.
By End User
8.3.2. Germany Exosome
Therapeutics Market Outlook
8.3.2.1.
Market Size & Forecast
8.3.2.1.1.
By Value
8.3.2.2.
Market Share & Forecast
8.3.2.2.1.
By Exosome Type
8.3.2.2.2.
By Source
8.3.2.2.3.
By Therapy
8.3.2.2.4.
By Application
8.3.2.2.5.
By End User
8.3.3. United Kingdom
Exosome Therapeutics Market Outlook
8.3.3.1.
Market Size & Forecast
8.3.3.1.1.
By Value
8.3.3.2.
Market Share & Forecast
8.3.3.2.1.
By Exosome Type
8.3.3.2.2.
By Source
8.3.3.2.3.
By Therapy
8.3.3.2.4.
By Application
8.3.3.2.5.
By End User
8.3.4. Italy Exosome
Therapeutics Market Outlook
8.3.4.1.
Market Size & Forecast
8.3.4.1.1.
By Value
8.3.4.2.
Market Share & Forecast
8.3.4.2.1.
By Exosome Type
8.3.4.2.2.
By Source
8.3.4.2.3.
By Therapy
8.3.4.2.4.
By Application
8.3.4.2.5.
By End User
8.3.5. Spain Exosome
Therapeutics Market Outlook
8.3.5.1.
Market Size & Forecast
8.3.5.1.1.
By Value
8.3.5.2.
Market Share & Forecast
8.3.5.2.1.
By Exosome Type
8.3.5.2.2.
By Source
8.3.5.2.3.
By Therapy
8.3.5.2.4.
By Application
8.3.5.2.5.
By End User
9.
Asia-Pacific Exosome Therapeutics Market Outlook
9.1. Market Size &
Forecast
9.1.1. By Value
9.2. Market Share &
Forecast
9.2.1. By Exosome Type
9.2.2. By Source
9.2.3. By Therapy
9.2.4. By Application
9.2.5. By End User
9.2.6. By Country
9.3. Asia-Pacific:
Country Analysis
9.3.1. China Exosome
Therapeutics Market Outlook
9.3.1.1.
Market Size & Forecast
9.3.1.1.1.
By Value
9.3.1.2.
Market Share & Forecast
9.3.1.2.1.
By Exosome Type
9.3.1.2.2.
By Source
9.3.1.2.3.
By Therapy
9.3.1.2.4.
By Application
9.3.1.2.5.
By End User
9.3.2. India Exosome
Therapeutics Market Outlook
9.3.2.1.
Market Size & Forecast
9.3.2.1.1.
By Value
9.3.2.2.
Market Share & Forecast
9.3.2.2.1.
By Exosome Type
9.3.2.2.2.
By Source
9.3.2.2.3.
By Therapy
9.3.2.2.4.
By Application
9.3.2.2.5.
By End User
9.3.3. Japan Exosome
Therapeutics Market Outlook
9.3.3.1.
Market Size & Forecast
9.3.3.1.1.
By Value
9.3.3.2.
Market Share & Forecast
9.3.3.2.1.
By Exosome Type
9.3.3.2.2.
By Source
9.3.3.2.3.
By Therapy
9.3.3.2.4.
By Application
9.3.3.2.5.
By End User
9.3.4. South Korea Exosome
Therapeutics Market Outlook
9.3.4.1.
Market Size & Forecast
9.3.4.1.1.
By Value
9.3.4.2.
Market Share & Forecast
9.3.4.2.1.
By Exosome Type
9.3.4.2.2.
By Source
9.3.4.2.3.
By Therapy
9.3.4.2.4.
By Application
9.3.4.2.5.
By End User
9.3.5. Australia Exosome
Therapeutics Market Outlook
9.3.5.1.
Market Size & Forecast
9.3.5.1.1.
By Value
9.3.5.2.
Market Share & Forecast
9.3.5.2.1.
By Exosome Type
9.3.5.2.2.
By Source
9.3.5.2.3.
By Therapy
9.3.5.2.4.
By Application
9.3.5.2.5.
By End User
10. South America
Exosome Therapeutics Market Outlook
10.1.
Market Size & Forecast
10.1.1. By Value
10.2.
Market Share & Forecast
10.2.1. By Exosome Type
10.2.2. By Source
10.2.3. By Therapy
10.2.4. By Application
10.2.5. By End User
10.2.6. By Country
10.3.
South America: Country Analysis
10.3.1. Brazil Exosome
Therapeutics Market Outlook
10.3.1.1. Market Size & Forecast
10.3.1.1.1.
By Value
10.3.1.2. Market Share & Forecast
10.3.1.2.1.
By Exosome Type
10.3.1.2.2.
By Source
10.3.1.2.3.
By Therapy
10.3.1.2.4.
By Application
10.3.1.2.5.
By End User
10.3.2. Argentina Exosome Therapeutics
Market Outlook
10.3.2.1. Market Size & Forecast
10.3.2.1.1.
By Value
10.3.2.2. Market Share & Forecast
10.3.2.2.1.
By Exosome Type
10.3.2.2.2.
By Source
10.3.2.2.3.
By Therapy
10.3.2.2.4.
By Application
10.3.2.2.5.
By End User
10.3.3. Colombia Exosome
Therapeutics Market Outlook
10.3.3.1. Market Size & Forecast
10.3.3.1.1.
By Value
10.3.3.2. Market Share & Forecast
10.3.3.2.1.
By Exosome Type
10.3.3.2.2.
By Source
10.3.3.2.3.
By Therapy
10.3.3.2.4.
By Application
10.3.3.2.5.
By End User
11. Middle East and
Africa Exosome Therapeutics Market Outlook
11.1.
Market Size & Forecast
11.1.1. By Value
11.2.
Market Share & Forecast
11.2.1. By Exosome Type
11.2.2. By Source
11.2.3. By Therapy
11.2.4. By Application
11.2.5. By End User
11.2.6. By Country
11.3.
MEA: Country Analysis
11.3.1. South Africa Exosome
Therapeutics Market Outlook
11.3.1.1. Market Size & Forecast
11.3.1.1.1.
By Value
11.3.1.2. Market Share & Forecast
11.3.1.2.1.
By Exosome Type
11.3.1.2.2.
By Source
11.3.1.2.3.
By Therapy
11.3.1.2.4.
By Application
11.3.1.2.5.
By End User
11.3.2. Saudi Arabia Exosome
Therapeutics Market Outlook
11.3.2.1. Market Size & Forecast
11.3.2.1.1.
By Value
11.3.2.2. Market Share & Forecast
11.3.2.2.1.
By Exosome Type
11.3.2.2.2.
By Source
11.3.2.2.3.
By Therapy
11.3.2.2.4.
By Application
11.3.2.2.5.
By End User
11.3.3. UAE Exosome
Therapeutics Market Outlook
11.3.3.1. Market Size & Forecast
11.3.3.1.1.
By Value
11.3.3.2. Market Share & Forecast
11.3.3.2.1.
By Exosome Type
11.3.3.2.2.
By Source
11.3.3.2.3.
By Therapy
11.3.3.2.4.
By Application
11.3.3.2.5.
By End User
12. Market Dynamics
12.1.
Drivers
12.2.
Challenges
13. Market Trends &
Developments
13.1.
Recent Developments
13.2.
Mergers & Acquisitions
13.3.
Product Launches
14. Competitive
Landscape
14.1.
Business Overview
14.2.
Company Snapshot
14.3.
Products & Services
14.4.
Financials (As reported)
14.5.
Recent Developments
14.6.
SWOT Analysis
14.6.1. Aethlon Medical,
Inc.-Exosome Sciences
14.6.2. Aegle Therapeutics
14.6.3. Anjarium Biosciences
AG
14.6.4. Exogenus
Therapeutics SA
14.6.5. Lonza Group
14.6.6. Capricor
Therapeutics, Inc.
14.6.7. Avalon Globocare
Corp
14.6.8. Stem Cell Medicine
Ltd.
14.6.9. Evox Therapeutics
Limited
14.6.10. EV Therapeutics
Strategic
Recommendations